High expression levels of OAT2 and RFC1 were observed in 40 and 29% of pre-treated colorectal cancer specimens, respectively, whereas the corresponding normal colorectal epithelia were negative or weakly positive for the two transporters. The gene discussed is SLC22A7; the disease is colorectal cancer.